Tumor microenvironment differences between primary tumor and brain metastases

Abstract

The present review aimed to discuss contemporary scientific literature involving differences between the tumor microenvironment (TME) in melanoma, lung cancer, and breast cancer in their primary site and TME in brain metastases (BM). TME plays a fundamental role in the behavior of cancer. In the process of carcinogenesis, cells such as fibroblasts, macrophages, endothelial cells, natural killer cells, and other cells can perpetuate and progress carcinogenesis via the secretion of molecules. Oxygen concentration, growth factors, and receptors in TME initiate angiogenesis and are examples of the importance of microenvironmental conditions in the performance of neoplastic cells. The most frequent malignant brain tumors are metastatic in origin and primarily originate from lung cancer, breast cancer, and melanoma. Metastatic cancer cells have to adhere to and penetrate the blood–brain barrier (BBB). After traversing BBB, these cells have to survive by producing various cytokines, chemokines, and mediators to modify their new TME. The microenvironment of these metastases is currently being studied owing to the discovery of new therapeutic targets. In these three types of tumors, treatment is more effective in the primary tumor than in BM due to several factors, including BBB. Understanding the differences in the characteristics of the microenvironment surrounding the primary tumor and their respective metastasis might help improve strategies to comprehend cancer.

Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling

“…Currently, accumulating evidence has suggested that the tumor microenvironment plays important roles in tumor progression and therapeutic responses (20,21). The infiltration of immune cells as well as stromal cells in the tumor microenvironment has an impact on tumor progression and prognosis (22,23). The development of cutaneous melanoma therapies, especially immunotherapy, has improved clinical outcomes (2).…”

Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response

“…Most recently the putative role of SPMs and their precursors in the management of Covid-19 disease [ 99 ] were discussed A clinical pilot study including patients with coronary artery disease indeed demonstrated a beneficial effect of ω-3 supplementation on the lipid mediator profile: Pro-resolving mediators were restored in treated patients compared to non-treated individuals resulting in increased macrophage-driven uptake of clots. In a clinical trial focusing on patients with chronic pain a 4-week supplementation with SPM-enriched marine lipids resulted in significant reduction of pain and improved quality of life [ 100 , 101 , 102 , 103 ].…”

Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles

“…Unlike other RNA viruses such as influenza, CoVs possess proofreading mechanisms, thus accumulating mutation at a slower rate [8,9]. Global sequencing efforts during the course of the COVID-19 pandemic have nevertheless identified viral variants and mutational hotspots in the SARS-CoV-2 genome [10][11][12][13][14]. Thus far, the most notable SARS-CoV-2 variant carries a D614G mutation in the spike protein and has become the most prevalent strain across geographical locations, indicating a likely fitness advantage [15].…”